|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
|
|---|---|---|---|---|---|---|---|
| ASSETS | |||||||
| Current assets | |||||||
| Cash | |||||||
| Prepaid expenses | |||||||
| Total Current Assets | |||||||
| Marketable securities held in Trust Account | |||||||
| TOTAL ASSETS | |||||||
| LIABILITIES, CLASS A ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION, AND SHAREHOLDERS' DEFICIT | |||||||
| Current liabilities | |||||||
| Accounts Payable | |||||||
| Accounts payable and accrued expenses | |||||||
| Due to Sponsor | |||||||
| Promissory note - related party | |||||||
| Accrued offering costs | |||||||
| Total Current Liabilities | |||||||
| Deferred underwriting fee | |||||||
| TOTAL LIABILITIES | |||||||
| Class A ordinary shares subject to possible redemption, $0.0001 par value; 14,651,303 and 17,250,000 shares issued and outstanding at redemption value of $10.73 and $10.53 per share as of June 30, 2026 and December 31, 2025, respectively | |||||||
| SHAREHOLDERS' DEFICIT | |||||||
| Common stock | |||||||
| Class A ordinary shares not subject to redemption | |||||||
| Class B | |||||||
| Accumulated deficit | |||||||
| Total Shareholders' Deficit | |||||||
| Total Liabilities, Class A Ordinary Shares Subject to Possible Redemption, and Shareholders' Deficit |
Loading...
